Global ADHD Medications Market Growth (Status and Outlook) 2023-2028

Report ID: 1507846 | Published Date: Oct 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global ADHD Medications Market Size 2017-2028
        2.1.2 ADHD Medications Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 ADHD Medications Segment by Type
        2.2.1 Stimulant
        2.2.2 Non-stimulant
    2.3 ADHD Medications Market Size by Type
        2.3.1 ADHD Medications Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global ADHD Medications Market Size Market Share by Type (2017-2022)
    2.4 ADHD Medications Segment by Application
        2.4.1 Adult
        2.4.2 Children
    2.5 ADHD Medications Market Size by Application
        2.5.1 ADHD Medications Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global ADHD Medications Market Size Market Share by Application (2017-2022)
3 ADHD Medications Market Size by Player
    3.1 ADHD Medications Market Size Market Share by Players
        3.1.1 Global ADHD Medications Revenue by Players (2020-2022)
        3.1.2 Global ADHD Medications Revenue Market Share by Players (2020-2022)
    3.2 Global ADHD Medications Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 ADHD Medications by Regions
    4.1 ADHD Medications Market Size by Regions (2017-2022)
    4.2 Americas ADHD Medications Market Size Growth (2017-2022)
    4.3 APAC ADHD Medications Market Size Growth (2017-2022)
    4.4 Europe ADHD Medications Market Size Growth (2017-2022)
    4.5 Middle East & Africa ADHD Medications Market Size Growth (2017-2022)
5 Americas
    5.1 Americas ADHD Medications Market Size by Country (2017-2022)
    5.2 Americas ADHD Medications Market Size by Type (2017-2022)
    5.3 Americas ADHD Medications Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC ADHD Medications Market Size by Region (2017-2022)
    6.2 APAC ADHD Medications Market Size by Type (2017-2022)
    6.3 APAC ADHD Medications Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe ADHD Medications by Country (2017-2022)
    7.2 Europe ADHD Medications Market Size by Type (2017-2022)
    7.3 Europe ADHD Medications Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa ADHD Medications by Region (2017-2022)
    8.2 Middle East & Africa ADHD Medications Market Size by Type (2017-2022)
    8.3 Middle East & Africa ADHD Medications Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global ADHD Medications Market Forecast
    10.1 Global ADHD Medications Forecast by Regions (2023-2028)
        10.1.1 Global ADHD Medications Forecast by Regions (2023-2028)
        10.1.2 Americas ADHD Medications Forecast
        10.1.3 APAC ADHD Medications Forecast
        10.1.4 Europe ADHD Medications Forecast
        10.1.5 Middle East & Africa ADHD Medications Forecast
    10.2 Americas ADHD Medications Forecast by Country (2023-2028)
        10.2.1 United States ADHD Medications Market Forecast
        10.2.2 Canada ADHD Medications Market Forecast
        10.2.3 Mexico ADHD Medications Market Forecast
        10.2.4 Brazil ADHD Medications Market Forecast
    10.3 APAC ADHD Medications Forecast by Region (2023-2028)
        10.3.1 China ADHD Medications Market Forecast
        10.3.2 Japan ADHD Medications Market Forecast
        10.3.3 Korea ADHD Medications Market Forecast
        10.3.4 Southeast Asia ADHD Medications Market Forecast
        10.3.5 India ADHD Medications Market Forecast
        10.3.6 Australia ADHD Medications Market Forecast
    10.4 Europe ADHD Medications Forecast by Country (2023-2028)
        10.4.1 Germany ADHD Medications Market Forecast
        10.4.2 France ADHD Medications Market Forecast
        10.4.3 UK ADHD Medications Market Forecast
        10.4.4 Italy ADHD Medications Market Forecast
        10.4.5 Russia ADHD Medications Market Forecast
    10.5 Middle East & Africa ADHD Medications Forecast by Region (2023-2028)
        10.5.1 Egypt ADHD Medications Market Forecast
        10.5.2 South Africa ADHD Medications Market Forecast
        10.5.3 Israel ADHD Medications Market Forecast
        10.5.4 Turkey ADHD Medications Market Forecast
        10.5.5 GCC Countries ADHD Medications Market Forecast
    10.6 Global ADHD Medications Forecast by Type (2023-2028)
    10.7 Global ADHD Medications Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Amneal Pharmaceuticals
        11.1.1 Amneal Pharmaceuticals Company Information
        11.1.2 Amneal Pharmaceuticals ADHD Medications Product Offered
        11.1.3 Amneal Pharmaceuticals ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Amneal Pharmaceuticals Main Business Overview
        11.1.5 Amneal Pharmaceuticals Latest Developments
    11.2 Eli Lilly and Co.
        11.2.1 Eli Lilly and Co. Company Information
        11.2.2 Eli Lilly and Co. ADHD Medications Product Offered
        11.2.3 Eli Lilly and Co. ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Eli Lilly and Co. Main Business Overview
        11.2.5 Eli Lilly and Co. Latest Developments
    11.3 Johnson and Johnson Services
        11.3.1 Johnson and Johnson Services Company Information
        11.3.2 Johnson and Johnson Services ADHD Medications Product Offered
        11.3.3 Johnson and Johnson Services ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Johnson and Johnson Services Main Business Overview
        11.3.5 Johnson and Johnson Services Latest Developments
    11.4 NEOS Therapeutic
        11.4.1 NEOS Therapeutic Company Information
        11.4.2 NEOS Therapeutic ADHD Medications Product Offered
        11.4.3 NEOS Therapeutic ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 NEOS Therapeutic Main Business Overview
        11.4.5 NEOS Therapeutic Latest Developments
    11.5 Takeda Pharmaceutical
        11.5.1 Takeda Pharmaceutical Company Information
        11.5.2 Takeda Pharmaceutical ADHD Medications Product Offered
        11.5.3 Takeda Pharmaceutical ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Takeda Pharmaceutical Main Business Overview
        11.5.5 Takeda Pharmaceutical Latest Developments
    11.6 Pfizer
        11.6.1 Pfizer Company Information
        11.6.2 Pfizer ADHD Medications Product Offered
        11.6.3 Pfizer ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Pfizer Main Business Overview
        11.6.5 Pfizer Latest Developments
    11.7 Lupin
        11.7.1 Lupin Company Information
        11.7.2 Lupin ADHD Medications Product Offered
        11.7.3 Lupin ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Lupin Main Business Overview
        11.7.5 Lupin Latest Developments
    11.8 Shire
        11.8.1 Shire Company Information
        11.8.2 Shire ADHD Medications Product Offered
        11.8.3 Shire ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Shire Main Business Overview
        11.8.5 Shire Latest Developments
    11.9 Mallinckrodt
        11.9.1 Mallinckrodt Company Information
        11.9.2 Mallinckrodt ADHD Medications Product Offered
        11.9.3 Mallinckrodt ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Mallinckrodt Main Business Overview
        11.9.5 Mallinckrodt Latest Developments
12 Research Findings and Conclusion
List of Tables
    Table 1. ADHD Medications Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Stimulant
    Table 3. Major Players of Non-stimulant
    Table 4. ADHD Medications Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 5. Global ADHD Medications Market Size by Type (2017-2022) & ($ Millions)
    Table 6. Global ADHD Medications Market Size Market Share by Type (2017-2022)
    Table 7. ADHD Medications Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global ADHD Medications Market Size by Application (2017-2022) & ($ Millions)
    Table 9. Global ADHD Medications Market Size Market Share by Application (2017-2022)
    Table 10. Global ADHD Medications Revenue by Players (2020-2022) & ($ Millions)
    Table 11. Global ADHD Medications Revenue Market Share by Player (2020-2022)
    Table 12. ADHD Medications Key Players Head office and Products Offered
    Table 13. ADHD Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global ADHD Medications Market Size by Regions 2017-2022 & ($ Millions)
    Table 17. Global ADHD Medications Market Size Market Share by Regions (2017-2022)
    Table 18. Americas ADHD Medications Market Size by Country (2017-2022) & ($ Millions)
    Table 19. Americas ADHD Medications Market Size Market Share by Country (2017-2022)
    Table 20. Americas ADHD Medications Market Size by Type (2017-2022) & ($ Millions)
    Table 21. Americas ADHD Medications Market Size Market Share by Type (2017-2022)
    Table 22. Americas ADHD Medications Market Size by Application (2017-2022) & ($ Millions)
    Table 23. Americas ADHD Medications Market Size Market Share by Application (2017-2022)
    Table 24. APAC ADHD Medications Market Size by Region (2017-2022) & ($ Millions)
    Table 25. APAC ADHD Medications Market Size Market Share by Region (2017-2022)
    Table 26. APAC ADHD Medications Market Size by Type (2017-2022) & ($ Millions)
    Table 27. APAC ADHD Medications Market Size Market Share by Type (2017-2022)
    Table 28. APAC ADHD Medications Market Size by Application (2017-2022) & ($ Millions)
    Table 29. APAC ADHD Medications Market Size Market Share by Application (2017-2022)
    Table 30. Europe ADHD Medications Market Size by Country (2017-2022) & ($ Millions)
    Table 31. Europe ADHD Medications Market Size Market Share by Country (2017-2022)
    Table 32. Europe ADHD Medications Market Size by Type (2017-2022) & ($ Millions)
    Table 33. Europe ADHD Medications Market Size Market Share by Type (2017-2022)
    Table 34. Europe ADHD Medications Market Size by Application (2017-2022) & ($ Millions)
    Table 35. Europe ADHD Medications Market Size Market Share by Application (2017-2022)
    Table 36. Middle East & Africa ADHD Medications Market Size by Region (2017-2022) & ($ Millions)
    Table 37. Middle East & Africa ADHD Medications Market Size Market Share by Region (2017-2022)
    Table 38. Middle East & Africa ADHD Medications Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa ADHD Medications Market Size Market Share by Type (2017-2022)
    Table 40. Middle East & Africa ADHD Medications Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa ADHD Medications Market Size Market Share by Application (2017-2022)
    Table 42. Key Market Drivers & Growth Opportunities of ADHD Medications
    Table 43. Key Market Challenges & Risks of ADHD Medications
    Table 44. Key Industry Trends of ADHD Medications
    Table 45. Global ADHD Medications Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 46. Global ADHD Medications Market Size Market Share Forecast by Regions (2023-2028)
    Table 47. Global ADHD Medications Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 48. Global ADHD Medications Market Size Market Share Forecast by Type (2023-2028)
    Table 49. Global ADHD Medications Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 50. Global ADHD Medications Market Size Market Share Forecast by Application (2023-2028)
    Table 51. Amneal Pharmaceuticals Details, Company Type, ADHD Medications Area Served and Its Competitors
    Table 52. Amneal Pharmaceuticals ADHD Medications Product Offered
    Table 53. Amneal Pharmaceuticals ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 54. Amneal Pharmaceuticals Main Business
    Table 55. Amneal Pharmaceuticals Latest Developments
    Table 56. Eli Lilly and Co. Details, Company Type, ADHD Medications Area Served and Its Competitors
    Table 57. Eli Lilly and Co. ADHD Medications Product Offered
    Table 58. Eli Lilly and Co. Main Business
    Table 59. Eli Lilly and Co. ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. Eli Lilly and Co. Latest Developments
    Table 61. Johnson and Johnson Services Details, Company Type, ADHD Medications Area Served and Its Competitors
    Table 62. Johnson and Johnson Services ADHD Medications Product Offered
    Table 63. Johnson and Johnson Services Main Business
    Table 64. Johnson and Johnson Services ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 65. Johnson and Johnson Services Latest Developments
    Table 66. NEOS Therapeutic Details, Company Type, ADHD Medications Area Served and Its Competitors
    Table 67. NEOS Therapeutic ADHD Medications Product Offered
    Table 68. NEOS Therapeutic Main Business
    Table 69. NEOS Therapeutic ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 70. NEOS Therapeutic Latest Developments
    Table 71. Takeda Pharmaceutical Details, Company Type, ADHD Medications Area Served and Its Competitors
    Table 72. Takeda Pharmaceutical ADHD Medications Product Offered
    Table 73. Takeda Pharmaceutical Main Business
    Table 74. Takeda Pharmaceutical ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 75. Takeda Pharmaceutical Latest Developments
    Table 76. Pfizer Details, Company Type, ADHD Medications Area Served and Its Competitors
    Table 77. Pfizer ADHD Medications Product Offered
    Table 78. Pfizer Main Business
    Table 79. Pfizer ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 80. Pfizer Latest Developments
    Table 81. Lupin Details, Company Type, ADHD Medications Area Served and Its Competitors
    Table 82. Lupin ADHD Medications Product Offered
    Table 83. Lupin Main Business
    Table 84. Lupin ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 85. Lupin Latest Developments
    Table 86. Shire Details, Company Type, ADHD Medications Area Served and Its Competitors
    Table 87. Shire ADHD Medications Product Offered
    Table 88. Shire Main Business
    Table 89. Shire ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 90. Shire Latest Developments
    Table 91. Mallinckrodt Details, Company Type, ADHD Medications Area Served and Its Competitors
    Table 92. Mallinckrodt ADHD Medications Product Offered
    Table 93. Mallinckrodt Main Business
    Table 94. Mallinckrodt ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 95. Mallinckrodt Latest Developments
List of Figures
    Figure 1. ADHD Medications Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global ADHD Medications Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global ADHD Medications Market Size Market Share by Type in 2021
    Figure 7. ADHD Medications in Adult
    Figure 8. Global ADHD Medications Market: Adult (2017-2022) & ($ Millions)
    Figure 9. ADHD Medications in Children
    Figure 10. Global ADHD Medications Market: Children (2017-2022) & ($ Millions)
    Figure 11. Global ADHD Medications Market Size Market Share by Application in 2021
    Figure 12. Global ADHD Medications Revenue Market Share by Player in 2021
    Figure 13. Global ADHD Medications Market Size Market Share by Regions (2017-2022)
    Figure 14. Americas ADHD Medications Market Size 2017-2022 ($ Millions)
    Figure 15. APAC ADHD Medications Market Size 2017-2022 ($ Millions)
    Figure 16. Europe ADHD Medications Market Size 2017-2022 ($ Millions)
    Figure 17. Middle East & Africa ADHD Medications Market Size 2017-2022 ($ Millions)
    Figure 18. Americas ADHD Medications Value Market Share by Country in 2021
    Figure 19. Americas ADHD Medications Consumption Market Share by Type in 2021
    Figure 20. Americas ADHD Medications Market Size Market Share by Application in 2021
    Figure 21. United States ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 22. Canada ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 23. Mexico ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Brazil ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 25. APAC ADHD Medications Market Size Market Share by Region in 2021
    Figure 26. APAC ADHD Medications Market Size Market Share by Application in 2021
    Figure 27. China ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Japan ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Korea ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Southeast Asia ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 31. India ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Australia ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Europe ADHD Medications Market Size Market Share by Country in 2021
    Figure 34. Europe ADHD Medications Market Size Market Share by Type in 2021
    Figure 35. Europe ADHD Medications Market Size Market Share by Application in 2021
    Figure 36. Germany ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 37. France ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 38. UK ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Italy ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Russia ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Middle East & Africa ADHD Medications Market Size Market Share by Region in 2021
    Figure 42. Middle East & Africa ADHD Medications Market Size Market Share by Type in 2021
    Figure 43. Middle East & Africa ADHD Medications Market Size Market Share by Application in 2021
    Figure 44. Egypt ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 45. South Africa ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Israel ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Turkey ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 48. GCC Country ADHD Medications Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Americas ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 50. APAC ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 51. Europe ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 52. Middle East & Africa ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 53. United States ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 54. Canada ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 55. Mexico ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 56. Brazil ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 57. China ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 58. Japan ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 59. Korea ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 60. Southeast Asia ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 61. India ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 62. Australia ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 63. Germany ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 64. France ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 65. UK ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 66. Italy ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 67. Russia ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 68. Spain ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 69. Egypt ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 70. South Africa ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 71. Israel ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 72. Turkey ADHD Medications Market Size 2023-2028 ($ Millions)
    Figure 73. GCC Countries ADHD Medications Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global ADHD Medications Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global ADHD Medications Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global ADHD Medications Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports